The first quarter is in the books, and the S&P 500’s best and worst performers are a pharmacy chain and a footwear company—certainly not the usual suspects.CVS Health was the N0. 1 stock with a gain ...

Regarding market performance, Rowland highlighted that the S&P 500 earnings were coming in with ... 63 Year-to-Date Performance as of February 17: 46.65% CVS Health Corporation (NYSE:CVS) provides ...

We’re nearing the end of the calendar-year Q1, with many S&P 500 stocks delivering strong performances year-to-date despite recent volatility stemming from tariff talks and other economic developments ...

CVS Health surged 10% intraday and ended yesterday 6% higher. Check out why I think that CVS stock offers a significant ...

The healthcare sector, as measured by Health Care Select Sector SPDR Fund (NYSEARCA:XLV), with 12.12% weightage on the S&P 500, bagged a ... look at the sector’s performance and where its ...

CVS Health (CVS) closed the most recent trading day at $67.91, moving +0.5% from the previous trading session. This change lagged the S&P 500's 1.08% gain on the day. Meanwhile, the Dow gained 0. ...

S&P 500 hits lowest close in almost ... hinting at an improvement in performance in its first full quarter under new CEO David Joyner. CVS Health investors will closely examine this week ...

Q1’s top S&P 500 performers held strong despite tariffs ... Analyst consensus shows only Newmont and CVS have potential upside of 25.8% and 13.2%, respectively, based on median price targets.

In the most recent trading session, CVS Health (CVS) closed at $68.07, indicating a +0.13% shift from the previous trading day. While many stocks in the S&P 500 ETF posted dismal performance in the ...

The best-performing S&P 500 stocks of Q1 2025 include CVS Health, Philip Morris, Newmont, and AT&T, all outperforming amid ...